Pharmaceuticals and healthcare business Ascendis has not had a good year. In fact, it does not have a good three-or five-year history.

The business, which listed on the JSE in November 2013, was bankrolled by well-known private equity team Coast2Coast, which, aside from being a material shareholder in Ascendis, also drove the highly ambitious acquisition strategy.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now